Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat leadership changes will occur in the U.S. Attorney's Office for D.C. by June 30, 2025?
New leadership team announced • 25%
Fitzpatrick continues with current team • 25%
Temporary leadership changes • 25%
Other • 25%
Official announcements from the U.S. Attorney's Office or Department of Justice
DC US Attorney Matthew Graves, Lead January 6 Prosecutor, Resigns Before Trump's Inauguration
Dec 30, 2024, 07:00 PM
Matthew Graves, the U.S. Attorney for the District of Columbia who led the prosecution of over 1,000 individuals related to the January 6, 2021 Capitol attack, has announced he will resign effective January 16, 2025, just days before President-elect Donald Trump's inauguration. The United States Attorney's Office for D.C. confirmed Graves' resignation. Bridget Fitzpatrick, the principal assistant U.S. Attorney, will serve as acting U.S. Attorney upon his departure. Graves' tenure included overseeing the largest investigation in the Department of Justice's history addressing the events of January 6.
View original story
Bridget M. Fitzpatrick • 25%
Another Biden appointee • 25%
A Trump appointee • 25%
Other • 25%
No Change Announced • 25%
New Nominee Announced • 25%
Christopher Wray Retained • 25%
Kash Patel Appointed • 25%
Pam Bondi confirmed • 25%
Current leadership remains • 25%
Other • 25%
Another Republican appointee • 25%
New Director appointed • 25%
No leadership changes • 25%
Both Director and Deputy Director replaced • 25%
New Deputy Director appointed • 25%
Deputy leadership changes • 25%
Other changes • 25%
No leadership changes • 25%
Director replaced • 25%
Unclear • 25%
Complete overhaul • 25%
Partial changes • 25%
No significant changes • 25%
Negative impact • 25%
Mixed impact • 25%
Positive impact • 25%
No significant change • 25%
January 6-related prosecutions • 25%
Violent crime reduction • 25%
Gun and drug-related violence • 25%
Other • 25%
Other • 25%
Cybersecurity Measures • 25%
Immigration Enforcement • 25%
Criminal Justice Reform • 25%
No significant impact • 25%
Other • 25%
Cases expedited • 25%
Cases delayed • 25%